Masimo Corporation (MASI) common stock ceased trading on the Nasdaq Stock Market following the successful completion of its multi-billion-dollar acquisition by Danaher Corporation, which bought out all outstanding shares. Because the enterprise transitioned into a wholly-owned subsidiary operating privately within Danaher's diagnostics segment, public retail investors can no longer purchase individual shares of Masimo on open public exchanges.